REAL-WORLD EXPERIENCE OF GLECAPREVIR/PIBRENTASVIR TREATMENT IN JAPANESE ADOLESCENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

被引：0

作者：

Mizuochi, Tatsuki ^{[1
]}

Iwama, Itaru ^{[2
]}

Inui, Ayano ^{[3
]}

Ito, Yoshinori ^{[4
]}

Takaki, Yugo ^{[5
]}

Mushiake, Sotaro ^{[6
]}

Tokuhara, Daisuke ^{[7
]}

Ishige, Takashi ^{[8
]}

Ito, Koichi ^{[9
]}

Murakami, Jun ^{[10
]}

Hishiki, Haruka ^{[11
]}

Mikami, Hitoshi ^{[12
]}

Bessho, Kazuhiko ^{[13
]}

Kato, Ken ^{[1
]}

Yasuda, Ryosuke ^{[1
]}

Yamashita, Yushiro ^{[1
]}

Tanaka, Yasuhito ^{[14
,15
,16
]}

Tajiri, Hitoshi ^{[17
]}

机构：

[1] Kurume Univ, Pediat & Child Hlth, Sch Med, Kurume, Fukuoka, Japan

[2] Saitama Childrens Med Ctr, Gastroenterol & Hepatol, Saitama, Japan

[3] Saiseikai Yokohamashi Tobu Hosp, Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan

[4] Nagoya Univ, Pediat, Grad Sch Med, Nagoya, Aichi, Japan

[5] Japanese Red Cross Kumamoto Hosp, Pediat, Kumamoto, Japan

[6] Kindai Univ, Pediat, Nara Hosp, Higashiosaka, Osaka, Japan

[7] Osaka City Univ, Pediat, Grad Sch Med, Osaka, Japan

[8] Gunma Univ, Pediat, Grad Sch Med, Gunma, Japan

[9] Nagoya City Univ, Grad Sch Med Sci, Pediat & Neonatol, Nagoya, Aichi, Japan

[10] Tottori Univ, Pediat & Perinatol, Fac Med, Tottori, Japan

[11] Chiba Univ Hosp, Pediat, Chiba, Japan

[12] Iwate Prefectural Cent Hosp, Pediat, Morioka, Iwate, Japan

[13] Osaka Univ, Grad Sch Med, Pediat, Osaka, Japan

[14] Kumamoto Univ, Dept Gastroenterol & Hepatol, Fac Life Sci, Kumamoto, Japan

[15] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Nagoya, Aichi, Japan

[16] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan

[17] Kindai Univ, Pediat, Fac Med, Higashihiroshima, Japan

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4803

引用

页码：S1524 / S1525

页数：2

共 50 条

[1] Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
Mizuochi, Tatsuki
Iwama, Itaru
Inui, Ayano
Ito, Yoshinori
Takaki, Yugo
Mushiake, Sotaro
Tokuhara, Daisuke
Ishige, Takashi
Ito, Koichi
Murakami, Jun
Hishiki, Haruka
Mikami, Hitoshi
Bessho, Kazuhiko
Kato, Ken
Yasuda, Ryosuke
Yamashita, Yushiro
Tanaka, Yasuhito
Tajiri, Hitoshi
JOURNAL OF GASTROENTEROLOGY, 2023, 58 (04) : 405 - 412
[2] Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
Tatsuki Mizuochi
Itaru Iwama
Ayano Inui
Yoshinori Ito
Yugo Takaki
Sotaro Mushiake
Daisuke Tokuhara
Takashi Ishige
Koichi Ito
Jun Murakami
Haruka Hishiki
Hitoshi Mikami
Kazuhiko Bessho
Ken Kato
Ryosuke Yasuda
Yushiro Yamashita
Yasuhito Tanaka
Hitoshi Tajiri
Journal of Gastroenterology, 2023, 58 : 405 - 412
[3] Real-World Effectiveness and Safety of Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: A Prospective Cohort Study in Portugal
Vera, Jose
Gomes, Andre
Povoas, Diana
Seixas, Diana
Maltez, Fernando
Pedroto, Isabel
Maia, Luis
Mota, Margarida
Vieira, Maria Joao
Manata, Maria Jose
Ferreira, Paula
Lino, Sara
Guedes, Tiago P. E. R. E. I. R. A.
Marques, Nuno
ACTA MEDICA PORTUGUESA, 2024, 37 (05) : 323 - 333
[4] Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
Liu, Chen-Hua
Liu, Chun-Jen
Hung, Chien-Ching
Hsieh, Szu-Min
Su, Tung-Hung
Sun, Hsin-Yun
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Kao, Jia-Horng
LIVER INTERNATIONAL, 2020, 40 (04) : 758 - 768
[5] Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study
Ogawa, Eiichi
Furusyo, Norihiro
Nakamuta, Makoto
Nomura, Hideyuki
Satoh, Takeaki
Takahashi, Kazuhiro
Koyanagi, Toshimasa
Kajiwara, Eiji
Dohmen, Kazufumi
Kawano, Akira
Ooho, Aritsune
Azuma, Koichi
Kato, Masaki
Shimoda, Shinji
Hayashi, Jun
HEPATOLOGY RESEARCH, 2019, 49 (06) : 617 - 626
[6] Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection
Mensa, Federico J.
Lovell, Sandra
Pilot-Matias, Tami
Liu, Wei
FUTURE MICROBIOLOGY, 2019, 14 (02) : 89 - 110
[7] Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
Mullhaupt, Beat
Semela, David
Ruckstuhl, Lisa
Magenta, Lorenzo
Clerc, Olivier
Torgler, Ralph
Negro, Francesco
Semmo, Nasser
SWISS MEDICAL WEEKLY, 2021, 151
[8] Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection in adults
Nehra, V
Rizza, S. A.
Temesgen, Z.
DRUGS OF TODAY, 2018, 54 (07) : 407 - 421
[9] Glecaprevir/Pibrentasvir for the Treatment of Patients with Chronic Hepatitis C Virus Infection: Updated Real-World Data from the German Hepatitis C-Registry
Wiegand, Johannes
Naumann, Uwe
Stoehr, Albrecht
Sick, Christoph
John, Christine
Teuber, Gerlinde
Schiffelholz, Willibold, Sr.
Mauss, Stefan
Lohmann, Kristina
Koenig, Bettina
Pangerl, Andreas
Simon, Karl-Georg
HEPATOLOGY, 2018, 68 : 364A - 364A
[10] Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective Study
Su, Pei-Yuan
Chen, Yang-Yuan
Lai, Jun-Hung
Chen, Hung-Ming
Yao, Chih-Ta
Liu, I-Ling
Zeng, Ya-Huei
Huang, Siou-Ping
Hsu, Yu-Chun
Wu, Shun-Sheng
Siao, Fu-Yuan
Yen, Hsu-Heng
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)

← 1 2 3 4 5 →